We have found a low to absent Sema4A expression in bronchioalveolar, papillary, and small cell lung cancer but stage-dependent increased levels of Sema4A in adenocarcinoma and squamous cell carcinoma (Figure 4). This evidence concerns the gene SEMA4A and adenocarcinoma.